From October 1, 2023 to December 31, 2023, the company has repurchased 4,329,000 shares, representing 3.08% for $225.59 million. With this, the company has completed the repurchase of 9,371,000 shares, representing 8.1% for $474.77 million under the buyback announced on March 12, 2020.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
63.05 USD | -1.10% | +23.75% | +19.27% |
13/05 | Morgan Stanley Raises Price Target on Globus Medical to $67 From $57, Keeps Equalweight Rating | MT |
10/05 | Globus Medical Insider Sold Shares Worth $1,300,000, According to a Recent SEC Filing | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.27% | 8.61B | |
-5.04% | 182B | |
+2.32% | 111B | |
-2.68% | 68.48B | |
+1.16% | 49.69B | |
+7.89% | 44.46B | |
+2.33% | 40.67B | |
+21.83% | 31.22B | |
+1.65% | 26.09B | |
+15.30% | 25.32B |
- Stock Market
- Equities
- GMED Stock
- News Globus Medical, Inc.
- Tranche Update on Globus Medical, Inc.'s Equity Buyback Plan announced on March 12, 2020.